Article
Accelerated Cure Project for multiple sclerosis (MS), with its iConquerMS™ People-Powered Research Network initiative, is collaborating with Quest Diagnostics and the National Multiple Sclerosis Society to study immune response to COVID-19 vaccinations of people living with multiple sclerosis.
The study will employ a decentralized clinical trial model by which Quest's national network of patient service centers will enable participants to conveniently provide periodic blood specimens.
Read more about the study here.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.